Financials
Financial year 2025
Dr. Maarten Haemels - Nucleaire geneeskunde from Machelen (Brab.), company number BE0749910760, closed financial year 2025 with a result of € 44,861 after tax. For that financial year Dr. Maarten Haemels - Nucleaire geneeskunde recorded a gross margin of € 91,224 and equity of € 165,620. Compared with financial year 2024, the result moved from € 41,929 to € 44,861. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ 165,620
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 44,861
▲ 7% vs 2024
Profit after tax over the fiscal year.
€ 132,265
▲ 22% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 44,895 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
Debts at end 2025
€ 394,617
▼ 8% vs 2024
€ 33,967 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.
€ 981
Supplier invoices still open on the last day of the fiscal year.
€ 9,734
▲ 224% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 89,008 | € 112,508 | € 93,401 | € 91,224 | ▼ 2% |
| Profit after taxes | € 47,968 | € 61,123 | € 41,929 | € 44,861 | ▲ 7% |
| Equity | € 62,603 | € 123,725 | € 165,654 | € 165,620 | |
| Total debts | € 388,005 | € 487,617 | € 432,026 | € 443,494 | ▲ 3% |
| Cash | € 106,098 | € 106,073 | € 108,275 | € 132,265 | ▲ 22% |
| Land & buildings | € 339,738 | € 501,303 | € 478,261 | € 455,220 | ▼ 5% |
| Retained profit | € 57,603 | € 118,725 | € 160,654 | € 160,620 | |
| Dividend | € 0 | € 0 | € 0 | € 44,895 | |
| Bank debt | € 335,573 | € 460,942 | € 428,044 | € 394,617 | ▼ 8% |
| Balance sheet total | € 450,608 | € 611,343 | € 597,679 | € 609,113 | ▲ 2% |
Key figures of Dr. Maarten Haemels - Nucleaire geneeskunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. Maarten Haemels - Nucleaire geneeskunde?
What happened at Dr. Maarten Haemels - Nucleaire geneeskunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 44,861 (▲ 7% vs 2024). Source: NBB ↗
- New establishment in Machelen (Brab.). KBO
- Start of the company according to the CBE. KBO
In short
From € 47,968 profit in 2022 to € 44,861 profit in 2025.
Paid € 70,464 in corporate taxes since 2022.
Best year ever: 2023, with € 61,123 profit.
Paid out € 44,895 in dividends to the owners in total.
A new publication or filing at Dr. Maarten Haemels - Nucleaire geneeskunde? We notify you, reason included.
Follow Dr. Maarten Haemels - Nucleaire geneeskundeDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dr. Maarten Haemels - Nucleaire geneeskunde is MAARTEN HAEMELS.
Directors
According to the 2025 annual accounts
MAARTEN HAEMELS
Director
Establishments
Establishment units
Physical locations of this company
Koning Albertlaan 144
1830 Machelen (Brab.)
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0749.910.760
- VAT number
- BE 0749.910.760
- Registered office
- Koning Albertlaan 144, 1830 Machelen (Brab.)
- Names & denominations
- Dr. Maarten Haemels - Nucleaire geneeskunde
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 July 2020
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Activiteiten van medisch specialisten